Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Capital Leases: 2009-2018

Historic Capital Leases for Ironwood Pharmaceuticals (IRWD) over the last 9 years, with Dec 2018 value amounting to $158,000.

  • Ironwood Pharmaceuticals' Capital Leases was N/A to $158,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $158,000, marking a year-over-year change of. This contributed to the annual value of $158,000 for FY2018, which is N/A change from last year.
  • According to the latest figures from FY2018, Ironwood Pharmaceuticals' Capital Leases is $158,000, which was up 92.68% from $82,000 recorded in FY2016.
  • Ironwood Pharmaceuticals' Capital Leases' 5-year high stood at $2.6 million during FY2014, with a 5-year trough of $82,000 in FY2016.
  • Its 2-year average for Capital Leases is $120,000, with a median of $120,000 in 2016.
  • Data for Ironwood Pharmaceuticals' Capital Leases shows a maximum YoY plummeted of 88.10% (in 2015) over the last 5 years.
  • Over the past 4 years, Ironwood Pharmaceuticals' Capital Leases (Yearly) stood at $2.6 million in 2014, then plummeted by 88.10% to $306,000 in 2015, then crashed by 73.20% to $82,000 in 2016, then reached $158,000 in 2018.